Luminex Corporation (NASDAQ:LMNX) today announced that management will
present at the UBS Global Life Sciences Conference to be held September
22-24, 2008, in New York City.
The investor presentation by Patrick J. Balthrop, president and chief
executive officer, will begin at 9:00 a.m. Eastern time on Wednesday,
September 24, 2008. The presentation will be webcast live and may be
accessed at Luminex Corporation's website at http://www.luminexcorp.com.
Simply log on to the web at the address above, go to the Company section
and access the Investor Relations link. Please go to the website at
least 15 minutes prior to the event to register, download and install
any necessary audio/video software. If you are unable to participate
during the live webcast, the presentation will be archived for one year
on the website using the 'replay' link.
Luminex Corporation develops, manufactures and markets proprietary
biological testing technologies with applications throughout the life
sciences industry. The Company's xMAP® system
is an open-architecture, multi-analyte technology platform that delivers
fast, accurate and cost-effective bioassay results to markets as diverse
as pharmaceutical drug discovery, clinical diagnostics and biomedical
research, including the genomics and proteomics research markets. The
Company's xMAP technology is sold worldwide and is in use in leading
research laboratories as well as major pharmaceutical, diagnostic and
biotechnology companies. Further information on Luminex Corporation or
xMAP can be obtained on the Internet at http://www.luminexcorp.com.
Luminex Corporation
Mimi Torrington, 512-219-8020
Director of
Investor Relations
mtorrington@luminexcorp.com
or
Harriss
T. Currie, 512-219-8020
Vice President, Finance and Chief Financial
Officer
hcurrie@luminexcorp.com
